160 related articles for article (PubMed ID: 3480977)
1. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
[No Abstract] [Full Text] [Related]
2. The effect of propionyl L-carnitine on skeletal muscle metabolism in renal failure.
Thompson CH; Irish AB; Kemp GJ; Taylor DJ; Radda GK
Clin Nephrol; 1997 Jun; 47(6):372-8. PubMed ID: 9202867
[TBL] [Abstract][Full Text] [Related]
3. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
[No Abstract] [Full Text] [Related]
4. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
[TBL] [Abstract][Full Text] [Related]
5. [Carnitine metabolism in chronic kidney failure].
Fiorini F; Patrone E; Castellucci A
Clin Ter; 1992 Jan; 140(1 Pt 2):31-4. PubMed ID: 1559320
[TBL] [Abstract][Full Text] [Related]
6. [Plasma l-carnitine in patients with chronic hemodialysis. II. Pharmacokinetics of l-carnitine and its replacement therapy in these patients].
Kudoh Y; Shoji T; Oimatsu H; Kikuchi K; Imura O; Watarai I
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):195-202. PubMed ID: 6748336
[No Abstract] [Full Text] [Related]
7. Quantitative assessment of carnitine loss during haemodialysis and haemofiltration.
Rumpf KW; Leschke M; Eisenhauer T; Becker K; Köthe U; Scheler F
Proc Eur Dial Transplant Assoc; 1983; 19():298-301. PubMed ID: 6878244
[TBL] [Abstract][Full Text] [Related]
8. L-carnitine in dialysed patients: the choice of dosage regimen.
Berard E; Iordache A; Barrillon D; Bayle J
Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
[TBL] [Abstract][Full Text] [Related]
9. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
11. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
12. [L-carnitine in peritoneal dialysis].
De Vecchi AF; Arduini A; Di Liberato L; Bonomini M
G Ital Nefrol; 2011; 28(4):393-400. PubMed ID: 21809308
[TBL] [Abstract][Full Text] [Related]
13. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
Günal AI; Celiker H; Dönder E; Günal SY
J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
[TBL] [Abstract][Full Text] [Related]
14. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
16. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
[TBL] [Abstract][Full Text] [Related]
17. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneal dialysis in the treatment of chronic renal failure].
Kazimirov VG; Butrin SV; Bekov RR; Sapozhnikov AD; Kharitonov BI; Smoliakov AM; Detinenko IN
Urologiia; 2004; (5):58-62. PubMed ID: 15560166
[TBL] [Abstract][Full Text] [Related]
19. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
[TBL] [Abstract][Full Text] [Related]
20. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
Moorthy AV; Rosenblum M; Rajaram R; Shug AL
Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
